Supernus Pharmaceuticals, Inc. (SUPN)
47.64
-0.69
(-1.43%)
USD |
NASDAQ |
May 19, 16:00
47.64
0.00 (0.00%)
After-Hours: 16:07
Supernus Pharmaceuticals EPS Diluted (Quarterly) : -0.0398 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -0.2988 |
| Johnson & Johnson | 2.141 |
| Amphastar Pharmaceuticals, Inc. | 0.1382 |
| Assertio Holdings, Inc. | -2.931 |
| Eli Lilly & Co. | 8.255 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.293M |
| Revenue (Quarterly) | 207.70M |
| Total Expenses (Quarterly) | 210.00M |
| Enterprise Value | 2.462B |
| Gross Profit Margin (Quarterly) | 76.15% |
| Profit Margin (Quarterly) | -1.10% |
| Earnings Yield | -1.07% |
| Normalized Earnings Yield | -0.7485 |